Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
6.15%
correction
Passive
—
2024-12-20
Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
6.15%
change
Passive
—
2024-04-24
Nakatani Co.,Ltd.
5.01%
correction
Passive
—
2024-04-16
Nakatani Co.,Ltd.
5.01%
change
Passive
—
2024-02-06
Baillie Gifford & Co
4.96%
change
Passive
—
Capital Allocation Signals 1
Date
Type
Amount
Summary
2026-05-14
15:30
Special Div
¥11.9B ¥19.0/sh+12%
Sysmex CORPORATION board resolved on 2026-05-14 to pay a dividend of ¥19 per share (¥11.9 billion total) as of 2026-03-3…
Summary
Sysmex CORPORATION board resolved on 2026-05-14 to pay a dividend of ¥19 per share (¥11.9 billion total) as of 2026-03-31, combining ordinary dividend of ¥18 and commemorative dividend of ¥1 in recognition of the company's 30th anniversary of listing. This marks a year-over-year increase from ¥17 to ¥19 per share, bringing full-year dividend to ¥38 per share with a consolidated payout ratio of 67.3%.